Should children with Bell's palsy be treated with corticosteroids? A systematic review

M S Salman1, D L MacGregor

  • 1Division of Neurology, Hospital for Sick Children, Toronto, ON, Canada. Michael.Salman@sickkids.on.ca

Insights

This systematic review found no clear evidence that corticosteroids benefit children with Bell

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Background:

  • Bell's palsy is a common neurological disorder affecting facial nerves in children.
  • Corticosteroids are frequently used to treat Bell's palsy, but their efficacy in pediatric cases is debated.

Purpose of the Study:

  • To systematically review existing evidence on the use of corticosteroids for treating pediatric Bell's palsy.
  • To evaluate the effectiveness and safety of steroid treatment in children under 16.

Main Methods:

  • Systematic review of eight clinical trials involving pediatric Bell's palsy patients.
  • Included trials used prednisone or corticotropin; five were randomized controlled trials.
  • Limited reporting on randomization and allocation concealment methods; only one trial focused exclusively on children.

Main Results:

  • Four trials suggested potential benefits of corticosteroids.
  • The single pediatric-exclusive trial found no evidence of corticosteroid benefit.
  • Significant heterogeneity across studies precluded a meta-analysis.

Conclusions:

  • Current evidence does not support the routine use of corticosteroids for pediatric Bell's palsy.
  • Further high-quality research specifically in children is needed to clarify treatment benefits.